Nuwellis, Inc. (NUWE)

NASDAQ: NUWE · IEX Real-Time Price · USD
+0.03 (1.90%)
Sep 28, 2023, 10:06 AM EDT - Market open

Company Description

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy.

The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics.

Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.

The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama.

Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom.

The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021.

Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Nuwellis, Inc.
Nuwellis logo
Country United States
Founded 1999
Industry Medical Devices
Sector Healthcare
Employees 70
CEO Nestor Jaramillo Jr.

Contact Details

12988 Valley View Road
Eden Prairie, Minnesota 55344
United States
Phone 952-345-4200

Stock Details

Ticker Symbol NUWE
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001506492
CUSIP Number 12542Q706
ISIN Number US12542Q7060
Employer ID 68-0533453
SIC Code 3845

Key Executives

Name Position
Nestor Jaramillo Jr. President, Chief Executive Officer and Director
Neil P. Ayotte Esq. Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Lynn L. Blake CPA, M.B.A. Chief Financial Officer
Rob Scott Senior Director of Financial Planning and Analysis and Interim Principal Accounting Officer
William Colon M.D. Vice President of Marketing
John Kowalczyk Vice President of Sales
Sandra Eayrs Chief Human Resources Officer
Vitaliy Epshteyn Senior Vice President of Operations and Engineering
Paul Wotta Corporate Controller
Laurent Duhoux Vice President of International Business Development

Latest SEC Filings

Date Type Title
Sep 21, 2023 S-1 General form for registration of securities under the Securities Act of 1933
Aug 18, 2023 8-K Current Report
Aug 8, 2023 10-Q Quarterly Report
Aug 8, 2023 8-K Current Report
Aug 8, 2023 8-K Current Report
Jun 26, 2023 D Notice of Exempt Offering of Securities
Jun 21, 2023 8-K Current Report
Jun 5, 2023 8-K Current Report
May 25, 2023 SD Form - SD
May 22, 2023 8-K Current Report